Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F3 | P13726 | 2/20 | 0.77 |
| ▸ | MAOB | P27338 | 10/20 | 0.75 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.75 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 4/20 | 0.72 |
| ▸ | NPC1 | O15118 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | MAOA | P21397 | 4/20 | 0.69 |
| ▸ | XDH | P47989 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | P4HB | P07237 | 1/20 | 0.69 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.69 |
| ▸ | RAB9A | P51151 | 1/20 | 0.69 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.67 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.67 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.67 |
| ▸ | BCHE | P06276 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2665209 | 1.00 | F3 (0.77) | F3MAOBCYP1B1CYP1A1MAPT | |
| SCHEMBL2646833 | 1.00 | F3 (0.77) | F3MAOBCYP1B1CYP1A1MAPT | |
| SCHEMBL2647392 | 0.93 | CYP2D6 (0.63) | F3MAOBCYP1B1CYP1A1MAPT | |
| SCHEMBL2648725 | 0.89 | MAOB (0.69) | F3MAOBCYP1B1CYP1A1MAPT | |
| SCHEMBL2648722 | 0.89 | MAOB (0.69) | F3MAOBCYP1B1CYP1A1MAPT | |
| SCHEMBL2665078 | 0.89 | MAOB (0.69) | F3MAOBCYP1B1CYP1A1MAPT | |
| 4,4'-Dimethoxychalcone SCHEMBL978243 | 0.88 | F3 (1.00) | F3MAOBCYP1B1CYP1A1MAPT | |
| 4,4'-Dimethoxychalcone SCHEMBL978242 | 0.88 | F3 (1.00) | F3MAOBCYP1B1CYP1A1MAPT | |
| SCHEMBL25202905 | 0.87 | XDH (0.67) | F3MAOBCYP1B1CYP1A1MAPT | |
| SCHEMBL25196548 | 0.87 | XDH (0.67) | F3MAOBCYP1B1CYP1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1463715-A1 | NOVEL GLUCAGON ANTAGONISTS | NOVO NORDISK A/S (DK) | 2004-10-06 | — | — | EP | disclosed |
| US-6762318-B2 | CARBOXYLIC ACID OR TETRAZOLE DERIVATIZED SECONDARY AMIDES; ORAL ADMINISTRATION | NOVO NORDISK A/S (DK) | 2004-07-13 | — | — | US | disclosed |
| US-20030236292-A1 | Stimulant releasing glucose from liver cells; antidiabetic agents | PFIZER INC | 2003-12-25 | — | — | US | disclosed |
| WO-2003048109-A1 | NOVEL GLUCAGON ANTAGONISTS | NOVO NORDISK A/S (DK) | 2003-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236292-A1 | Stimulant releasing glucose from liver cells; antidiabetic agents | GPR119, GLP1R, GIPR | F3 4692/4885MAOB 3317/4885CYP1B1 3336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.